These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10727)

  • 21. Plasma prorenin: cryoactivation and relationship to renin substrate in normal subjects.
    Sealey JE; Moon C; Laragh JH; Alderman M
    Am J Med; 1976 Nov; 61(5):731-8. PubMed ID: 10728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pH and enzyme inhibitors on apparent generation of angiotensin I in human plasma.
    Oparil S; Koerner TJ; Haber E
    J Clin Endocrinol Metab; 1974 Nov; 39(5):965-8. PubMed ID: 4370811
    [No Abstract]   [Full Text] [Related]  

  • 25. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
    Hiramatsu K; Yamada T; Yukimura Y; Komiya I; Ichikawa K; Ishihara M; Nagata H; Izumiyama T
    Arch Intern Med; 1981 Nov; 141(12):1589-93. PubMed ID: 7030245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of oral contraceptive therapy on the renin-angiotensin system in normotensive and hypertensive women.
    Tapia HR; Johnson CE; Strong CG
    Obstet Gynecol; 1973 May; 41(5):643-9. PubMed ID: 4348864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of "angiotensin immunoreactive material" in rat kidney.
    Morris BJ; Johnston CI
    Endocrinology; 1977 May; 100(5):1409-17. PubMed ID: 191245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis.
    Sansoé G; Silvano S; Mengozzi G; Todros L; Smedile A; Touscoz G; Rosina F; Rizzetto M
    J Hepatol; 2004 Mar; 40(3):417-23. PubMed ID: 15123355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Night-day variations of renin-activity in primary aldosteronism.
    Siebenschein R; Vetter W; Leinert R; Siegenthaler W; Vetter H
    Horm Metab Res; 1979 Oct; 11(10):570-3. PubMed ID: 574849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.
    Wong PY; Talamo RC; Williams GH; Colman RW
    J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay of plasma renin activity.
    Fyhrquist F; Soveri P; Puutula L; Stenman UH
    Clin Chem; 1976 Feb; 22(2):250-6. PubMed ID: 2393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients.
    Bragat AC; Blumenfeld J; Sealey JE
    J Hypertens; 1997 May; 15(5):459-65. PubMed ID: 9169997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Direct radioimmunochemical determination of plasmatic renin activity].
    Vincent M; Geyssant A; Sassard J
    C R Seances Soc Biol Fil; 1972; 166(4):643-8. PubMed ID: 4346795
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.
    Saruta T; Suzuki H; Handa M; Igarashi Y; Kondo K; Senba S
    J Clin Endocrinol Metab; 1986 Feb; 62(2):275-9. PubMed ID: 3510223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 37. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Variations of the renin aldosterone system in Cushing's disease (author's transl)].
    Bricaire H; Thibonnier M; Hautecouverture M; Corvol P; Luton JP
    Nouv Presse Med; 1980 Mar; 9(14):1007-9. PubMed ID: 6988802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme inhibitors for renin assay in rat plasma.
    Tikkanen I; Fyhrquist F; Puutula-Räsänen L
    Clin Sci (Lond); 1980 Nov; 59(5):381-3. PubMed ID: 6775860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating renin in essential hypertension: an evaluation of its significance in the Japanese population.
    Abe K; Irokawa N; Aoyagi H; Memezawa H; Yasujima M
    Am Heart J; 1975 Jun; 89(6):723-30. PubMed ID: 1130265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.